David Emerson Jorden, Director, 10% Owner at CYTOMEDIX INC (CMXI), bought 252,000 shares at $0.36 ($84K) on 2011-05-02, disclosed to the SEC on 2011-05-03.
Open-market purchase of $84k CMXI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.33 | 218,334 | $72K | 85.6% |
| 2 | $0.36 | 33,666 | $12K | 14.4% |
| Total | $0.33 avg | 252,000 | $84K | 100% |
| Filing → |
| AURX | BUY | 2017-08-14 | $54K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |